相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
Panagiotis A. Konstantinopoulos et al.
CANCER RESEARCH (2011)
Drug transporters of platinum-based anticancer agents and their clinical significance
Herman Burger et al.
DRUG RESISTANCE UPDATES (2011)
Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer
Jonathan A. Ledermann et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Clinical Trials in Recurrent Ovarian Cancer
Michael Friedlander et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
miR-200a Regulates Nrf2 Activation by Targeting Keap1 mRNA in Breast Cancer Cells
Gabriel Eades et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance
Gang Ye et al.
JOURNAL OF CELL SCIENCE (2011)
miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1
Fanfei Kong et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2011)
MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma
Yukako Imanaka et al.
JOURNAL OF HUMAN GENETICS (2011)
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
Bogdan Mateescu et al.
NATURE MEDICINE (2011)
Carcinoma Matrix Controls Resistance to Cisplatin through Talin Regulation of NF-kB
Karen E. Eberle et al.
PLOS ONE (2011)
Suppression of NF-κB signaling by KEAP1 regulation of IKKβ activity through autophagic degradation and inhibition of phosphorylation
Jeong-Eun Kim et al.
CELLULAR SIGNALLING (2010)
Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
Dawn R. Cochrane et al.
JOURNAL OF ONCOLOGY (2010)
MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response
Joris Pothof et al.
EMBO JOURNAL (2009)
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
Dawn R. Cochrane et al.
MOLECULAR CANCER THERAPEUTICS (2009)
KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ
Dung-Fang Lee et al.
MOLECULAR CELL (2009)
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Ulrich Wellner et al.
NATURE CELL BIOLOGY (2009)
Repertoire of microRNAs in Epithelial Ovarian Cancer as Determined by Next Generation Sequencing of Small RNA cDNA Libraries
Stacia K. Wyman et al.
PLOS ONE (2009)
Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients
Michael F. Gallagher et al.
JOURNAL OF OVARIAN RESEARCH (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
Nuo Yang et al.
CANCER RESEARCH (2008)
MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
Platinum resistance: The role of DNA repair pathways
Lainie P. Martin et al.
CLINICAL CANCER RESEARCH (2008)
MicroRNA expression profiles in serous ovarian carcinoma
Eun Ji Nam et al.
CLINICAL CANCER RESEARCH (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
Manav Korpal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1
John F. Reichard et al.
NUCLEIC ACIDS RESEARCH (2007)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
Mechanisms of resistance to cisplatin and carboplatin
David J. Stewart
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance
Anamaria Brozovic et al.
CANCER LETTERS (2007)
MicroRNA expression profiles for the NCI-60 cancer cell panel
Paul E. Blower et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Characterization of microRNA expression levels and their biological correlates in human cancer cell lines
Arti Gaur et al.
CANCER RESEARCH (2007)
Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-κB transactivation
KJ Campbell et al.
CANCER RESEARCH (2006)
Treatment issues in clear cell carcinoma of the ovary: A different entity?
Dimitrios Pectasides et al.
ONCOLOGIST (2006)
Biological and chemical inhibitors of NF-κB sensitize SiHa cells to cisplatin-induced apoptosis
M Venkatraman et al.
MOLECULAR CARCINOGENESIS (2005)
Utility of siRNA against Keap1 as a strategy to stimulate a cancer chemopreventive phenotype
TWP Devling et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the downregulation of putative targets during differentiation
YS Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of NFκB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models
S Mabuchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors
H Motohashi et al.
GENE (2002)
Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein - Implication for heme oxygenase-1 gene regulation
CH He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
